Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. ACN
10. USO

Go back to Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026
(NASDAQ: MNPR) Delayed: 81.77 +13.11 (19.09%)
Previous Close $68.66    52 Week High $ 
Open $68.21    52 Week Low $ 
Day High $83.57    P/E N/A 
Day Low $68.21    EPS $ 
Volume 278,171